NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

Good spot.

But, I think this Professor doesn't really know.

It sounds just like the repeating of mischievous rumour.

And in any event, it is not the FDA's role to 'look into' companies.

Do we know if he is a site investigator for the trial, I wonder?

I think the possible issue regarding repeated leukapheresis as forwarded by aboobmove might be relevant here.

Though ,if I recall, Dr Bosch stated that, in practice, a requirement for a repeated leuk was rare.